Increased alanine aminotransferase level as a predictive marker of hand-foot syndrome in patients receiving capecitabine: A retrospective cohort study
Journal of Oncology Pharmacy Practice
Published online on October 24, 2025
Abstract
Journal of Oncology Pharmacy Practice, Ahead of Print.
IntroductionHand-foot syndrome (HFS) is a common dose-limiting toxicity of capecitabine that impairs quality of life and can lead to treatment modification or discontinuation. Predictive markers for HFS remain unclear. This study aimed to identify ...
IntroductionHand-foot syndrome (HFS) is a common dose-limiting toxicity of capecitabine that impairs quality of life and can lead to treatment modification or discontinuation. Predictive markers for HFS remain unclear. This study aimed to identify ...